Flagship Pioneering and GSK announce a collaboration to discover and develop a portfolio of novel medicines and vaccines

Noubar Afeyan, Founder and CEO of Flagship Pioneering, shared a post by Flagship Pioneering on X, adding:

“Pioneering new therapies that can transform the lives of patients demands that we continue to ask ourselves how we can create medicines faster and more effectively.

Partnerships like our newest alliance with GSK aim to do just that.

Together with GSK we will leverage the strengths of our organizations to innovate a pipeline of new medicines and continue to demonstrate how connecting our Flagship ecosystem with pharma through these novel partnerships can bring about ever bigger leaps in drug discovery and development.”

Quoting Flagship Pioneering’s post:

“Flagship and GSK announce a strategic collaboration to discover and develop a portfolio of novel medicines and vaccines, starting in respiratory and immunology.

Read the full announcement about our latest Innovation Supply Chain Partnership which will leverage GSK’s disease expertise and development capability together with Flagship’s ecosystem of pioneering bioplatforms.”

Source: Noubar Afeyan/X and Flagship Pioneering/X